RocketTickers,True,2019-02-14 15:13:00,55.523,RARE 20190214 083000 Ultragenyx and Kyowa Kirin Announce Positive 64Week Results for Crysvita burosumab from Phase 3 Study
cctranscripts,,2019-02-14 14:17:00,55.37,T ROWE PRICE ASSOCIATES INC just provided an update on share ownership of Ultragenyx Pharmac conferencecalltranscriptso RARE
